NEWS: Amerge Cleocin Fioricet Cefixime! Diamox Dutasteride Foradil Lamisil Leflunomide Ciprofloxacin Diethylpropion Digoxin? Losartan Meridia Levlen Prempro Premphase Aricept Oseltamivir Mometasone! Phentermine Ionamin Crestor Accupril Diovan Neurontin Clomiphene Hydrocodone? Esomeprazole Phendimetrazine. Cyclobenzaprine Lisinopril. Minipress Enalapril Altace Diethylpropion Azithromycin Accolate Pravastatin Celebrex Encare Famvir Celebrex Flovent Hydroxyzine Furosemide. Advair Coreg Nortriptyline Pediacare: Clopidogrel Altace Aldara Avalide Aldactone Estraderm Buspirone Percocet Dovonex Avandamet Gemfibrozil Noroxin Avandamet Plendil Clonazepam Famotidine Afrin Minocin Fosamax Ceclor! Muse Lansoprazole Femara Aciphex Paxil Beconase Naprosyn Crestor? Cleocin Paroxetine Fastin Combivent! Klonopin Atorvastatin Apomorphine Insulin! Indapamide Naprosyn Famvir Ibuprofen Cosopt Atrovent Lamisil Cordarone Cytomel Bromocriptine Beconase Azithromycin Differin Glucophage! Vicodin Cardizem Meridia Indapamide Oxycodone Ambien. Allegra Fioricet Flomax Pravachol Pantoprazole Amoxil Keflex Feldene Prempro Pioglitazone Catapres Aldactone Ionamin Pentasa Ditropan Levothyroxine Lysodren Arava Clomipramine Macrodantin. Lozol Aldara, Methylphenidate Ditropan Zithromax Cephalexin: Kaopectate Flexeril Flutamide Ansaid Ceclor Lanoxin! Multivitamins Nitrofurantoin Amiloride Adapalene, Mometasone Mobic Prednisone Lysodren Alka seltzer Lozol, Noroxin Diflucan Famotidine Celecoxib Alavert Augmentin Itraconazole Lopid? Diprolene Fastin? Bayer Hydroxyurea: Divalproex Nolvadex: Locoid Tramadol Metoprolol Diprolene? Hydrochlorothiazide Cipro Lovastatin Lamotrigine Prevacid Cytotec Ampicilin Citalopram Cimetidine Chromium Lisinopril Mevacor Arimidex Bactrim Ecotrin Cetirizine Ephedrine Muse Lodine Flutamide Permax Caffeine Nicorette Prevacid? Donepezil Differin Imuran Clopidogrel Losec Ecotrin Amaryl Metformin! Cephalexin Esomeprazole Accupril Diamox, Premarin Levofloxacin, Avapro Cytomel! Colace Claritin. Flonase Asa Gabapentin Amlodipine Naproxen Lamictal Atorvastatin Losec Lopressor Clomipramine. Anafranil Piroxicam Estraderm Lorazepam, Hyzaar Lotrimin Amoxicillin Paxil Botox Glyburide Lexapro Glucotrol Bupropion Dovonex Pediacare Divalproex Coreg Dilantin Piroxicam Nicotrol! Bromocriptine Imuran! Calan Imodium Methocarbamol Lasix Pravachol Alavert Accolate Clomiphene Enalapril Mycostatin Estrace Lexapro Carvedilol Metoprolol Amoxil Glipizide Atropine Methylphenidate, Finasteride Aspirin Arthrotec Levoxyl Epivir Letrozole Nolvadex Locoid Glucophage Avapro! Diflucan Nystatin Glipizide Flomax: Lamictal Ativan Plaquenil Plaquenil. Celecoxib Buspirone Doxycycline Lopressor, Percocet Lithium Asa Fluvastatin Fluconazole Femara Clomid Amphetamine. Flagyl Losartan Insulin Elocon Diclofenac Loprox Chlortrimeton Eulexin Nifedipine Nabumetone, Levitra Hydrocortisone Clarithromycin Viagra Orlistat Indocin Ativan Isotretinoin! Cetirizine Carisoprodol Nexium Imiquimod Flovent Gemfibrozil: Viagra Imdur Cardura Botox, Furosemide Inderal Lamotrigine Orlistat. Alendronate Cope Ambien Allegra Lorazepam Alprazolam Lopid Levitra, Luvox Aerobid Lanoxin Allopurinol Adipex Olanzapine Elidel Bayer Alesse Dulcolax: Atrovent Hydrochlorothiazide Imdur Pepcid Imodium Epo Imiquimod Motrin, Nystatin Bentyl! Estrogen Nadolol. Nicotrol Coumadin? Maxzide Gabapentin Ciprofloxacin Exelon Fluvastatin Climara Effexor Hyzaar. Oxycontin Prazosin: Aerobid Chlortrimeton Androgel Epivir Plendil Premarin Combivent Avodart: Fluoxetine Levlen Nasonex Encare, Prazosin Fluticasone Caffeine Elavil: Epo Alendronate Actos Nicorette Elocon Amoxicillin! Inderal Afrin Hydroxyurea Methocarbamol, Biaxin Flagyl! Prinivil Naltrexone! Diltiazem Budesonide Indomethacin Monopril Accutane Keflex. Neurontin Hytrin Celexa Donepezil Plavix Nifedipine: Macrobid Cafergot: Tramadol Lovastatin Macrodantin Capoten Lescol Doxycycline Glucotrol Phentermine: Claritin Hydroxyzine, Cordarone Clindamycin: Pepcid Albuterol Diazepam Micronase. Dilantin Zithromax Codeine Apomorphine! Bentyl Naproxen Citalopram Nizoral Carbamazepine Celexa: Lithium Ketoconazole Aspirin Oseltamivir Pioglitazone Fluoxetine. Eldepryl Phenytoin Levaquin Adalat Naltrexone Amitriptyline Clarinex Potassium Bactrim Carvedilol Captopril Estrogen Digoxin Estrace

Archive for May, 2007

Don’t fear uncontrolled messaging. Tame it.

Wednesday, May 30th, 2007

If you don’t have anything nice to say …

Although the leap into uncontrolled messaging through public relations programs can at first be frightening, if approached properly, the results can overwhelmingly succeed that of costly advertising and self-praising brochures. In a perfect world, you could pick and choose the information your organization communicated externally without limits - a messaging buffet, if you will. Unfortunately, neither advertising nor in-house collateral fall under the all-you-can eat category. That could, however, be a blessing in disguise. The power of third-party credibility just doesn’t translate into advertising, particularly in the B-to-B world. Editorial coverage gives readers the signal that someone, aside from your own company, believes your organization deserves merit. (more…)

Enjoy the long weekend . . . but before you do, think about this

Friday, May 25th, 2007

The numbers are in for 2006 and according to IAB (Interactive Advertising Bureau), online ad revenue in the U.S. is up 35% from the year before. By now it has top $17 billion and continues to climb. While much of that growth is attributed to consumer advertising, the B2B part of the pie continues to increase as well. We’ll share those specific numbers at a later date. In the meantime, I have one question: If you’re a B2B marketer and you’re not involved in online advertising, what are you waiting for?

Enjoy the long weekend!

Is quality writing really that important?

Thursday, May 24th, 2007

When desktop publishing and graphics software went mainstream in the 80s (remember MacPaint?), suddenly everyone could be a designer and create their own ads and brochures. Or so they thought. It took a while to realize that just because you can do something doesn’t mean you should do it. Time proved that software could not replace the creative talent and experience required to produce effective marketing pieces. History seems to be repeating itself in the area of PR writing. (more…)

MySpace for “Our Kind”

Wednesday, May 23rd, 2007

Lawrence Ragan Communications Inc., one of the leading training companies for external and internal communications worldwide, just launched MyRagan.com; and it’s already being described as “the MySpace of the PR industry.” With 3,000 registered users in the first two weeks, it seems this is the ‘it’ thing for ‘our kind.’ The goal of the project is to provide a social network for PR, Graphic Design, Marketing and Web professionals to swap tips, resources and strategies.

Will it work? I’m not sure. But there is no way to find out unless we try. Sign Up and ‘Friend Me’.

Microsoft buys aQuantive

Friday, May 18th, 2007

The battle for online media supremacy just took a major turn of events today as Microsoft announced the purchase of aQuantive - an Ad serving and network business.

(more…)

Twitterpated

Thursday, May 17th, 2007

Call me old-fashioned, but I still think the telephone is the best way to reach out and touch someone. Perhaps that’s why Twitter, one of the Web’s recent micro-blogging sensations, seemed frivolous to me when I first saw it.

(more…)

Viral Marketing- Explained

Tuesday, May 15th, 2007

Viral Marketing- Champagne Audience on a Beer Budget

Friday, May 11th, 2007

Viral Marketing has caused quite a stir in the marketing world recently, something similar to what Reality-TV has done for network television. (more…)

Blogs are Credible – I swear!

Friday, May 11th, 2007

What do you think - Are blogs more credible than news outlets? Industry publications? White papers? Analyst reports? Industry professional associations?

A recent study by KnowledgeStorm and Universal McCann polled 4500 people. More than 50% answered that blogs are equally or more credible than each of those outlets. At first that really astonished me. But, the truth is, a third-party endorsement is so valuable, especially for B2B. And blogs are a great example of this. (View Complete Statistics)

Moral of the story – blogs are here to stay as credible sources for every industry. When you are planning your next PR pitch or news release, don’t forget to add them to your media list. Also, simply commenting on blogs is a great way to break into the sphere.

Get busy. Potential sales leads are reading.

Eye Candy?

Thursday, May 10th, 2007

So you think interactive media is all the rage, given its tracking capabilities, eh? Well, you’re right, of course, but the development of new technology has not stopped at the doorstep of the Internet. Other media are getting into the act as well. Talk about accountability. Check out this little item from townhall.com (via AdvertisingLab):

Device Enables Tracking Ads by the View

A Canadian professor has developed technology that allows advertisers to count the number of people who look at their billboards and screens. (more…)